Download PDF
Horm Metab Res 2011; 43(5): 297-299
DOI: 10.1055/s-0031-1273762
Hypothesis

© Georg Thieme Verlag KG Stuttgart · New York

Underexpression of C-myc in Adrenocortical Cancer: A Major Pathogenic Event?

P. M. Szabó1 , K. Rácz1 , P. Igaz1
  • 12ndDepartment of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary
Further Information

Publication History

received 04.11.2011

accepted 21.02.2011

Publication Date:
16 March 2011 (online)

Also available at
    Permissions and Reprints

Abstract

The protooncogene c-myc is a major factor in tumourigenesis. Whereas c-myc overexpression is considered to be a general feature of many tumours, we have recently demonstrated c-myc underexpression in adrenocortical cancer by a meta-analysis. We hypothesise that c-myc underexpression might be a central event in adrenortical tumourigenesis based on network topology modelling and previous experimental observations. In this brief hypothesis, we present our arguments and their possible relevance.

Key words

adrenal - tumour - meta-analysis - network

References

  • 1 Soucek L, Evan GI. The ups and downs of Myc biology.  Curr Opin Genetics Dev. 2010;  20 91-95
    Google Scholar
  • 2 Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease.  Oncogene. 1999;  18 3004-3016
    Google Scholar
  • 3 Szabó PM, Tamási V, Molnár V, Andrásfalvy M, Tömböl Z, Farkas R, Kövesdi K, Patócs A, Tóth M, Szalai C, Falus A, Rácz K, Igaz P. Meta-analysis of adrenocortical tumor genomics data: novel pathogenic pathways revealed.  Oncogene. 2010;  29 3163-3172
    Google Scholar
  • 4 Giordano TJ, Kuick R, Else T, Gauger PG, Vinco M, Bauersfeld J, Sanders D, Thomas DG, Doherty G, Hammer G. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling.  Clin Cancer Res. 2009;  15 668-676
    Google Scholar
  • 5 de Reyniès A, Assié G, Rickman DS, Tissier F, Groussin L, René-Corail F, Dousset B, Bertagna X, Clauser E, Bertherat J. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival.  J Clin Oncol. 2009;  27 1108-1115
    Google Scholar
  • 6 Tömböl Z, Szabó PM, Molnár V, Wiener Z, Tölgyesi G, Horányi J, Riesz P, Reismann P, Patócs A, Likó I, Gaillard RC, Falus A, Rácz K, Igaz P. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.  Endocr Relat Cancer.. 2009;  16 895-906
    Google Scholar
  • 7 Barabasi AL, Albert R. Emergence of scaling in random networks.  Science. 1999;  286 509-512
    Google Scholar
  • 8 Crucitti, Latora V, Marchiori M. Model for cascading failures in complex networks.  Phys Rev. 2004;  E 69 045104-1–045104-4
    Google Scholar
  • 9 Liu J, Voutilainen R, Kahri AI, Heikkilä P. Expression patterns of the c-myc gene in adrenocortical tumors and pheochromocytomas.  J Endocrinol. 1997;  152 175-181
    Google Scholar
  • 10 Heikkilä P, Arola J, Salmi A, Kahri AI. ACTH-induced c-myc proton-oncogene expression precedes antimitogenic effect during differentiation of fetal rat adrenocortical cells.  J Endocrinol. 1995;  145 379-385
    Google Scholar
  • 11 Liu J, Voutilainen R, Kahri AI, Heikkilä P. Expression of the c-myc gene in human adrenals: regulation by adrenocorticotropin in primary cultures.  J Endocrinol. 1996;  148 523-529
    Google Scholar
  • 12 Coulter CL. Fetal adrenal development: insight gained from adrenal tumors.  Trends Endocrinol Metab. 2005;  16 235-242
    Google Scholar
  • 13 Larsson LS, Henriksson MA. The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy.  Exp Cell Res. 2010;  316 1429-1437
    Google Scholar
  • 14 Gandarillas A, Watt FM. c-Myc promotes differentiation of human epidermal stem cells.  Genes Dev. 1997;  11 2869-2882
    Google Scholar
  • 15 Bettess MD, Dubois N, Murphy MJ, Dubey C, Roger C, Robine S, Trumpp A. c-Myc is required for the formation of intestinal crypts but dispensable for homeostasis of the adult intestinal epithelium.  Mol Cell Biol. 2005;  25 7868-7878
    Google Scholar
  • 16 Toftgard R, Roop DR, Yuspa SH. Proto-oncogene expression during two-stage carcinogenesis in mouse skin.  Carcinogenesis. 1985;  6 655-657
    Google Scholar
  • 17 Watson JV, Stewart J, Evan GI, Ritson A, Sikora K. The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer.  Br J Cancer. 1986;  53 331-337
    Google Scholar
  • 18 Fassnacht M, Allolio B. Clinical management of adrenocortical carcinoma.  Best Pract Res Clin Endocrinol Metab. 2009;  23 273-289
    Google Scholar
  • 19 Lepique AP, Moraes Ms, Rocha KM, Eichler CB, Hajj GNM, Schwindt TT, Armelin HA. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.  J Mol Endocrinol. 2004;  33 623-638
    Google Scholar
  • 20 Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, Davis AC, Ihle JN, Cleveland JL. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression.  Genes Dev. 2002;  16 2530-2543
    Google Scholar
  • 21 Bernini GP, Moretti A, Bonadio AG, Menicagli M, Viacava P, Naccarato AG, Iacconi P, Miccoli P, Salvetti A. Angiogenesis in human normal and pathologic adrenal cortex.  J Clin Endocrinol Metab. 2002;  87 4961-4965
    Google Scholar

Correspondence

Dr. P. IgazMD, MSc, PhD 

2nd Department of Medicine

Faculty of Medicine

Semmelweis University

Szentkiralyi street 46

1088 Budapest

Hungary

Phone: +36/1/4591 500

Fax: +36/1/2660 816

Email: igapet@bel2.sote.hu

      >